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ABSTRACT
The Effects of Inhibiting Wnt Secretion and Activity on Cranial
and Neural Development
Julie Louise Hulet
Department of Physiology and Developmental Biology, BYU
Master of Science
Wnt signaling has been shown to have several roles in the development of sensory
neurons, particularly in the ophthalmic portion of the trigeminal nerve. Many of these studies
have relied on the conclusion that Wnt is necessary but not sufficient for the induction and
maintenance of the neural precursor cells that develop in the ophthalmic placode. Wnt had been
inhibited in the ophthalmic placode using a dominant negative t-cell factor (TCF) and resulted in
the loss of Pax3 expression (indicative of undifferentiated placode cells) in all targeted cells,
suggesting a loss of specification/commitment of these cells to the sensory neuron fate. This
study aimed to build on that conclusion by identifying the source of Wnt signaling that allowed
for the maintenance of these placode cells. To investigate this, chick embryo ex ovo cultures
were used and treated with small molecule chemical Wnt inhibitors to globally knock out Wnt
signaling. The embryos were then sectioned and stained for cell markers of undifferentiated
placode and differentiated neural cells (Pax3 and Islet1, respectively). Also used was a
conditional knockout of Porcn, a gene critical to post-transcriptional modification of the Wnt
ligand, using Wnt1-cre as a driver; this allowed for the knockout of Wnt secretion from the
dorsal neural tube as well as neural crest cells. The data showed a decrease in placode cell
differentiation but did not indicate a necessity for Wnt in maintenance of the ophthalmic placode
cells—there was no loss of Pax3 expressing cells in the ectoderm. This suggested that
maintenance of the ophthalmic placode could be through alternate pathways. Data is also
presented describing how loss of Porcn in Wnt1 expressing cells impacts craniofacial
development, where the mouse mutant used in this study displayed the absence and
underdevelopment of cranial neural crest structures.
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INTRODUCTION
Cranial development and neural development in embryogenesis are both intricate
processes guided by a variety of pathways and signaling gradients. In addition to various
divisions, invaginations, folding, and other cell movements, there is very specific induction and
differentiation of cell populations to correctly develop each structure. Because of the many
factors involved in proper development, it’s hard to know what is responsible when
abnormalities occur. While there are many pathways that are active in and manage the specific
development of both general cranial and cranial neural structures, my goal was to examine the
source and roles of Wnt family members specific to cranial neuron development.
The major research focus of the Stark Lab at BYU has been to study sensory neuron
formation in vertebrates. Several studies from the group examined the role of various pathways,
such as FGF, Notch, and Wnt, to see how they contributed to the development of sensory
neurons (Lassiter et al., 2007, Voelkel et al., 2013, Lassiter et al., 2009). One particular study
that was surprising was that of the Wnt pathway and its role in the development of the
ophthalmic trigeminal placode; Wnt was seen to be necessary for not only induction but also
maintenance of the placode structure. While Wnts from the midbrain region have been
implicated in trigeminal placode cell development, they have additionally been seen to be critical
in the formation of the neural crest (NC) from this region (Lassiter et al., 2007, Adams 2012,
Canning et al., 2008, Brault et al., 2001; Chang and Hemmati-Brivanlou, 1998; Dorsky et al.,
1998; Garcia-Castro et al., 2002; Ikeya et al., 1997; LaBonne and Bronner-Fraser, 1998; Lewis
et al., 2004; Saint-Jeannet et al., 1997)). As you will see in this thesis, I happened upon a
potentially important NC phenotype while investigating Wnt function in sensory neuron
formation.
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Wnt family members are generally segregated into two categories: the canonical/βcatenin-dependent and the non-canonical/β-catenin-independent pathway. Wnt is a paracrine
pathway and thus a ligand is prepared and secreted from one cell and, in the canonical pathway,
binds to co-receptors frizzled and low-density lipoprotein receptor-related protein (LRP) on
another cell. This results in the phosphorylation and translocation of disheveled to the membrane
and Axin binding to LRP5/6, thus dissociating the destruction complex (which normally targets
β-catenin for degradation in the absence of Wnt). β-catenin then enters the nucleus and associates
with t-cell factor (TCF)/lymphoid-enhancing factor (LEF) receptors to activate transcription (Fig
1).
In past experiments, various methods have been used to interrupt the Wnt pathway and
determine how it’s involved in neural development (Lassiter et al., 2007, Adams 2012). A prime
area to study and isolate development of sensory neurons in particular has been the trigeminal
ganglion (cranial nerve V), which mediates touch, pain, and temperature of the face. It forms
from neural crest cells and two overlapping placodes: the ophthalmic (opV) and maxillomandibular (mmV) placodes (D'Amico-Martel and Noden, 1983; Hamburger, 1961). The
ophthalmic lobe of the trigeminal nerve specifically innervates the skin of the head as well as the
eye muscles and nose (Baker and Bronner 2001). The earliest expressed marker of these
specified cells (Pax3) was pinpointed and used to define important stages of development in the
opV placode—induction, specification, commitment, and differentiation (Stark et al., 1997).
Pax3 expression was then used as evidence of induction and maintenance of the opV placode in
response to inhibiting various signals. Lassiter et al. looked at the effects on Pax3 expression
when all neural tube (NT) signals were blocked and found that NT signaling was necessary in
opV placode induction (2007).
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Figure 1: Canonical Wnt Pathway.
When the Wnt ligand is present, it binds to co-receptors frizzled, a 7-pass transmembrane Gprotein coupled receptor, and low-density lipoprotein receptor-related protein (LRP) 5/6.
Disheveled (Dsh) is then phosphoryled and translocated to the membrane and Axin binds to
LRP5/6; this dissociates the destruction complex (normally composed of GSK3, APC, CK1 and
Axin) and allows for β-catenin to persist. β-catenin enters the nucleus and associates with t-cell
factor (TCF)/lymphoid-enhancing factor (LEF) receptors to activate transcription

3

Several Wnt family members had been shown to be expressed throughout the neural tube,
some as early as 3 somite stage (ss), with corresponding Frizzled receptor expression in the
cranial ectoderm and thus were used as candidates for induction of the opV placode (Lassiter et
al., 2007, Stark et al., 2000). By misexpressing a dominant negative (DN) TCF4 in placodal
ectoderm at various stages, Lassiter et al. found that placode cell formation was disrupted,
suggesting a requirement for Wnt in placode cell induction and maintenance (indicated by loss of
Pax3 expression) (2007). They also tested for sufficiency of the Wnt pathway by blocking all
NT/ectoderm interaction while at the same time adding in dominant active B-catenin and
observed no rescue, thus concluding that Wnt was necessary but not sufficient in opV placode
development. Recent work produced by Jason Adams investigated the role of specific Wnts—
Wnt1 and Wnt3a—in opV placode development by producing knockouts of each, individually,
in mice. Neither mutant strains showed any decrease in Pax3 expression. However, a doubleknockout of Wnt1 and Wnt3a showed diminished expression of Pax3 as well as diminished
development of the trigeminal nerve (Adams 2012, Ikeya et al., 1997). This was an important
discovery, since it left open the possibility that other Wnts were involved in the maintenance of
the opV placode.
Thus I looked at the manipulation of the gene Porcupine (Porcn) which codes for a
membrane-bound O-acyl transferase required for the post-transcriptional modification of all Wnt
proteins and thus ligand secretion. Mice from a Sox1-cre driver line were bred with Porcn
mutant mice to create a conditional knockout of Porcn in the NT (based on the expression of
Sox1). These mice showed no significant change in Pax3 expression. Upon investigation, it was
shown that, while Porcn was eliminated from the majority of NT cells, it was not knocked out in
all cells in the NT, particularly in a few cells in the dorsal neural folds where Wnt1 is expressed
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(Adams, 2012). The results left a few questions: what is the source of Wnt expression required in
maintenance of the opV placode? Is Wnt diffusing from the NT or is it expressed endogenously
(i.e. within the ectoderm) to maintain the opV placode?
Our aim was to broaden our inhibition of Wnt and observe the effects in vitro to define if
it is an endogenous signal or not. I did so by using two different chemical inhibitors (IWP-2 and
XAV939) in embryo tissue and explant culture: Inhibitor of Wnt Processing (IWP)-2 inactivates
Porcn, inhibits palmitoylation of Wnt, and prevents Wnt-dependent phosphorylation of Lrp6 and
disheveled in addition to causing accumulation of B-catenin (Chen et al., 2009); XAV939
inhibits Tankyrase, a Poly-ADP-ribosyltransferase, resulting in a prolonged half-life for Axin2
and increased degradation of B-catenin (Karlberg et al., 2010, Huang et al., 2009). While no
gross morphological effects were observed, the treatments led to a decrease in differentiated
placode cells. This might suggest that Wnt expression is not required in maintenance of the opV
placode as previously thought, but rather plays a role in allowing the cells to differentiate.
Alternatively it could provide the foundation of a new model of sensory neuron differentiation
wherein Pax3 is regulated by an alternate TCF-mediated pathway.
To clarify these potential models, I sought to more severely remove Wnt secretion in the
NT by using a new cre driver line, Wnt1-cre, and crossing it with a Porcn mutant. This knocked
out Wnt secretion from the NT as well as neural crest cells (NCC). While placode cell
differentiation did not seem to be disrupted, severe craniofacial abnormalities were observed.
These results led us to propose that Wnt, secreted from NCC, is required in craniofacial
development, specifically those derivative structures from the first, second, and third pharyngeal
arches.
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MATERIALS AND METHODS
Obtaining of Chicken Embryos and Incubation
Fertilized chicken eggs were obtained from Dunlap Hatchery in Caldwell, ID and were
incubated without rotation at 38 ̊C from 30-40 h to the 8-10 and 10-12 somite stage. When the
embryos had developed to the desired stage, an adapted version of the chick whole-embryo
culture developed by Susan Chapman et al. was used (Chapman 2001).

Explant Preparation
The eggs were cracked into a petri dish with the embryo top of the yolk. About 30 ml of
thin albumin was removed from the petri dish with a 10 ml syringe. The thick albumin that
surrounds the embryo and blastoderm was carefully moved away with a Kimwipe and a ring of
Whatman no 2 filter paper with an outer diameter of 1.0 inch and an inner hole cut to be about
0.5 inch in diameter. The ring was placed around the embryo so that the embryo was centered in
the ring. Scissors were used to cut out the vitelline membrane around ring’s circumference. After
the vitelline membrane has been detached from the yolk, it was removed and a second ring was
placed on the ventral side of the embryo creating a sandwich of two rings with the embryo and
vitelline membranes in the center.

Agar-Albumin Culture Dishes with Chemical Inhibitor
Agar culture dishes were prepared per Darnell and Schoenwolf’s protocol (2000). 0.72 g
of Bacto-Agar was mixed with boiling saline solution (7.19 g NaCl into 1 L distilled autoclaved
water) and put in a water bath at 45 ̊C for 20 min. Meanwhile, 120 mL of thin albumin was
collected from fertilized chicken eggs and Wnt antagonist XAV939, dissolved in
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dimethylsulfoxide (DMSO) was added in order to achieve a concentration of 100 µM while an
equivalent amount of DMSO was added to the control culture solution. After 20 min, the BactoAgar/saline solution was removed from the water bath and mixed with 120 µL
Penicillin/Streptomycin by swirling for 30-60 sec in a flow hood. This solution was then
aliquoted into separate tubes and mixed thoroughly with the previously measured DMSO or
XAV939 in the respective individual tubes. Thin albumin (2:1 ratio with the agar/saline solution)
was added and mixed well but gently enough to prevent the formation of bubbles. 2 mL of the
solutions was placed in separate wells in 6-well dishes. Each well was then covered and allowed
to set up for 3 h prior to use. The rings containing the embryos were laid gently in the separate
agar wells containing DMSO or Wnt-antagonist. These embryos were allowed to incubate at
37 ̊C for a total of 24 h.

Collection
Following the incubation period embryos were cut out of the ring and vitelline membrane
in a solution of 1X PBS. These same embryos were fixed in 1ml of 4% formaldehyde for one
hour at room temperature or at 2-8 ̊C over night. Following fixation, embryos were washed three
times with PBS, placed in 5% sucrose/PBS for 4h at room temperature, and then stored in 15%
sucrose/PBS at 2-8 ̊C until sectioning.

Cryosectioning
Embryos were prepared for cryosectioning by embedding them in gelatin consisting of
7.5 g gelatin (Sigma) and 15 g sucrose filled to a volume of 100 ml with 1xPBS. Each embryo, in
15% sucrose/PBS, was heated alongside the 15% gelatin to 37.5 ̊C for 20-30 min to equilibrate
temperatures. The embryo was then removed from the 15% sucrose/PBS with tweezers or a
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capillary pipette and placed into the warmed gelatin to sit for 2-3 h. Warmed gelatin was then
placed in a mold and the embryos were removed again with tweezers or a capillary pipette and
placed into a gelatin-filled mold. After positioning the embryo, the gelatin block was allowed to
sit for at least 30 min at room temperature and then stored in the refrigerator or taken and
prepared for sectioning. Each gelatin block was flash frozen in liquid nitrogen and sectioned at
10 µM with a cryostat, with the sections mounted in sequence on Superfrost Plus glass slides.

Immunohistochemistry
Embryo sections were rehydrated by placing them in PBS at room temperature for 30
min. Gelatin surrounding the embryo sections was removed by placing slides in 37 ̊C PBS for 510 min and then switching the slides to a new slide bath with warmed PBS for another 5-10 min,
or until gelatin was dissolved and no longer visible. The cryosections were then stained for the
expression of molecular markers Pax3, Islet1, and DAPI. Pax3 was used to mark cells that had
been specified to the opV cell fate (Stark et al., 1997). In addition, Islet1 was used to stain cells
that have undergone cell fate and committed to specify sensory neurons in the trigeminal
ganglion (Sun et al., 2008). Pax3 primary antibody (mouse IgG2a 488 secondary ) is diluted to a
1:500 concentration with PBS/BSA/Tween and Islet1 (mouse IgG2b 546 secondary) to a 1:500
concentration with the same mixture. Each antibody solution was allowed to sit at room
temperature for 10 min before application. 300μl was applied to each slide and stored at 25 ̊C for
4 h or overnight at 4 ̊C. Each slide was then washed with PBS and covered with 300μl of
secondary antibody diluted (1:1000) in PBS/BSA/Tween and stored for one hour at 25 ̊C.
Following the application of the secondary antibody, the slides were again washed with PBS and
cover-slipped. Fluorescent images of the staining were taken with an Olympus BX61
microscope.
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Collagen Matrix Cultures
After incubating the eggs to somite stage 8-10, the eggs were cracked and placed into a
petri dish. The embryo was cut out and placed into PBS with 1% penicillin-streptomycin. The
head of the embryo was removed and placed on ice in DMEM with 1% penicillin-streptomycin.
Explants were stored on ice in medium until ready to be placed in collagen gel culture. Collagen
matrix gels were prepared as previously described (Artinger and Bronner-Fraser, 1993) except
commercially produced collagen was used (Collaborative Research). The bottom layer
(20µLcollagen) was allowed to set for 5-7 min at room temperature before the explants were
added. The top layer (4µLcollagen) was allowed to set for 10 min at room temperature before
addition of medium plus N-2 supplements (Gibco-BRL). Wnt inhibitors XAV939 and IWP-2
were added to N-2 supplement media in concentrations from 5µM to 100µM. A corresponding
concentration of 0µM of DMSO was added to N-2 supplement media for the control. Cultures
were incubated at 38 ̊C, 5% CO2 for 24 h.

Preparation and Collection of Mouse Embryos
The Wnt1-cre driver line was obtained from the Jackson Labs (stock #022137) and was
cared for and breeded here with help from the Barrow Lab at Brigham Young University. A
conditional knock-out had been made using a female mouse heterozygous for a X-linked Porcn
knock-out obtained from the University of Utah (Barrott et al., 2011). When bred with the Cre
driver lines, it created a conditional knock-out of Porcn where Wnt1 is expressed (namely, in the
dorsal folds of the neural tube). The embryos were allowed to grow until embryonic day 8.5
(E8.5) and embryonic day 9.5 (E9.5). Then, the mother was sacrificed and the embryos were
removed from the uterus and fixed in paraformaldehyde. Sections of yolk sac were cut from each
embryo and placed in a tube with 2µLproteinase K and 100µLear lysis buffer, incubated
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overnight and then boiled. These were used to genotype the mouse embryos. Whole mount
imaging was done using bright field microscopy.

Genotyping
PCR was done on the yolk sac DNA (preparation described above) to determine the sex
of the embryos. Previously designed primers were used to amplify the SRY region of the
prepared DNA. Presence of the SRY and Cre genes indicated mutants in the litters.

Whole Mount In Situ Hybridization
A dioxygenin (DIG)-labeled RNA antisense probe was synthesize from a plasmid of
Axin2 (obtained from Clare Baker, Cambridge University, England). Whole mount in situ
hybridization was performed in chick embryos described Henrique et al. (1995). Briefly,
formaldehyde fixed embryos of appropriate developmental stages were buffered and exposed to
a DIG-labeled antisense RNA probe, which recognized the Axin2 mRNA transcripts. After
removal of the nonspecifically adhering probe, the embryos were incubated with an alkaline
phosphatase (AP) -labeled anti-DIG antibody, followed by a chromogenic substrate for AP. The
embryos were removed and washed in with 1%Tween/PBS and imaged with bright-field
microscopy.

Skeletal Preps
Fetuses were obtained at 18.5 days post conception (dpc) by caesarean section,
eviscerated, and fixed in 95% alcohol for 5 days. The fat pads are dissolved by incubating the
fetuses in acetone for 48 h. The fixed fetuses were then incubated in alizarin red/alcian blue stain
solution at 37 ̊C for 7-9 days and then washed 3 times in water. The fetuses were then incubated
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with Sodium tetra-borate with Trypsin (30% Sodium Borate, 1% trypsin) at 37 ̊C for 5-6 h. They
were cleared in grades KOH:glycerol solution--80% KOH:20%glycerol, 50% KOH: 50%
Glycerol, 20% KOH: 80% Glycerol, and lastly 100% glycerol for 48 h each.

Statistical Analysis
Sections were randomly selected using Research Randomizer Form 4.0V
(http://www.randomizer.org/form.htm) and cell counts were done using Olympus Cellsens
software. The populations of cells counted included Pax3 antibody expressing cells, Islet1
antibody expressing cells, and Pax3/Islet1 antibody coexpressing cells in the ectoderm and
mesenchyme. SAS software, version 9.4 (SAS Institue Inc., Cary, NC), was used to do a Oneway ANOVA and Tukey-Kramer test. One-way ANOVA was used to determine if the means of
all of the groups were equal or not. Tukey-Kramer test was used to show if and which means
differed significantly in the ANOVA. P-values of ≤0.05 were used to indicate statistical
significance.
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RESULTS
Global Inhibition of Wnt Activity Points to Wnt Involvement in Differentiation/Delamination
Only
In chicken embryos, placode induction occurs as early as the 4 ss (Stark et al., 1997,
McCabe et al., 2009). Past research has shown that opV placode cells are generally committed
over a protracted period beginning at about the 7-8ss and peaking h later at the 10-15ss (Stark et
al., 1997). Lassiter et al., found that Pax3 expression was strongly reduced in the placode when
electroporated with DN-TCF4, so I attempted to duplicate the result by chemically and globally
inhibiting Wnt and looking at Pax3 expression in the ectoderm and mesenchyme in the midbrain
region of the head.
I explanted chick embryos at the 8-10ss onto an agar/albumin (EC) culture medium
treated with DMSO or XAV939. The embryos were then incubated for 24 h and observed for
viability and morphological defects. All embryos were still alive but no obvious morphological
differences were observed between the Wnt-antagonist treated embryos and the control embryos.
Embryos were then cut out of the vitelline membrane and fixed in 4% formaldehyde. After
embedding the embryos in 15% sucrose gelatin, I cryosectioned them coronally through the
region of interest and stained them using antibodies to Pax3 (marker for placode cells) and Islet1
(marker for differentiated neural cells). Total cell counts from five random sections through the
placode region of embryos from each treatment type were compared and analyzed for statistical
significance. Those embryos that showed unhealthy morphology were not included in cell
counts/analysis. The experimental samples showed a decreasing trend in the number of cells
expressing both Islet1 and Pax3 in the mesenchyme (Fig 2C, 2F, Fig 3B). While the difference
was not statistically significant (Table 1), it did seem to support previous findings that Wnt was
involved in the delamination and differentiation of the placode cells, as seen by a reduction in the
12

number of delaminated Pax3/Islet1 expressing cells (Lassiter et al., 2007). These results did not
replicate the previous findings that Wnt was required to maintain Pax3.
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Figure 2: Inhibition of Wnt Signaling Via XAV939 in the Trigeminal Placode.
The sections are of the opV placode from embryos collected at 8-10ss and cultured on Agaralbumin dishes for 24 h. The sections were then stained for Pax3 and Islet1. (A-C) 20X
magnification of placode ectoderm and underlying mesenchyme of control embryos. (G-I) 20X
magnification of placode ectoderm and underlying mesenchyme of XAV939-treated embryos.
Many Pax3+/Islet1+ cells can be observed in both the treated and control embryos.
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Figure 3: Average Cell Counts Of Pax3+ (Undifferentiated Placode Cells), Islet1+
(Differentiated Cells), Pax3+/Islet1+ (Differentiated Placode Cells) and Total Cells Counted.
(A) Cell counts in the placodal ectoderm. (B) Cells counts in the mesenchyme. While there is a
trend toward a reduced number of Pax3+/Islet1+ cells in the mesenchyme between the control
and experimental embryos, this reduction is not statistically significant (p-value = 0.0695). Error
bars represent the standard error of the mean. DMSO (n=5), XAV939 (n=5).
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Table 1: Analysis Of Variance of Pax3+/Islet1+ Cells in the Mesenchyme.
Source

DF

SS

MS

F-value

p-value

Model

1

1556.82

1556.82

3.45

0.0695

Error

48

21669.68

451.45

Corrected Total

49

23226.50
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Collagen Cell Culture Confirms Trend Suggesting Wnt’s Role in Differentiation and
Delamination
To control for the possibility that our technical approach did not effectively deliver the
Wnt inhibitor to the dorsal embryo, I repeated the experiment using the collagen matrix tissue
culture (CMC) method and an additional Wnt inhibitor, Inhibitor of Wnt Processing (IWP-2). I
chose to use the two inhibitors in this experiment to establish whether the drug delivery was
successful, hoping to see specific phenotypes. I collected embryos from 8-10ss and removed
them from the vitelline membrane. I removed the heads, making an incision right above the first
somite, and placed them in tissue culture media. A mound of collagen was placed in the middle
of each well in a 12-well culture plate and allowed to set up. The embryo heads were then
carefully placed on the center of the collagen mound and covered with more collagen (treated
with 10x DMEM and pH balanced with sodium bicarbonate). The embryos were then surrounded
with 2 ml of N-2 supplemented DMEM culture media treated with either DMSO, 20 µM
XAV939, or 5 µM IWP-2. These were then incubated for 24 hours. These embryos were
processed as described previously with the EC culture embryos and analyzed for the number of
cells expressing Pax3 and Islet1 in the ectoderm and mesenchyme (Fig 4).
There were no distinct morphological differences between any of the embryo heads.
However, immunohistochemistry and statistical analysis showed that there was a significant
difference (p≤ 0.05) in dual Pax3 and Islet1 expression in the mesenchyme in both experimental
treatments (XAV939 and IWP-2) versus the control embryos, following the trend established
with the EC cultured embryos (Fig 4C, 4F, 4I, Fig 5, Table 2). These results only hint at the
previous conclusion that Wnt is involved in differentiation and delamination; Lassiter et al.
observed a complete loss of Pax3 expression (ophthalmic placode cells) in both the ectoderm and
mesenchyme, whereas I observed only a reduction in the number of differentiated placode cells
17

that had delaminated into the mesenchyme (2007). This leaves open the possibility that some
other signal is involved in differentiation and delamination or that Wnt was not being sufficiently
inhibited. Since there was no difference in the results between IWP-2 and XAV939, I opted to
move forward using XAV939.
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Figure 4: Inhibition of Wnt Signaling Via XAV939 and IWP-2 in the Trigeminal Placode.
The two different Wnt inhibitors used showed that inhibiting Wnt secretion and activity
throughout the embryo head prevented the differentiation of the placode cells. The sections are
of the opV placode from embryo heads collected at 8-10ss and cultured in collagen matrix and
tissue culture media for 24 h. The sections were then stained for Pax3 and Islet1. (A-C) Control
embryos treated with DMSO (20µM). (D-F) Experimental embryos treated with 5 µM XAV939.
(G-I) Embryos treated with 20µM IWP-2. There appears to be a reduced number of
Pax3+/Islet1+ cells in the mesenchyme between the control and both sets of experimental
embryos (C, F, I).
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Figure 5: Average Cell Counts Of Pax3+ (Undifferentiated Placode Cells), Islet1+
(Differentiated Cells), Pax3+/Islet1+ (Differentiated Placode Cells), and Total Cells Counted.
Average cell counts in the mesenchyme. There was a significant reduction of differentiated
placode cells found in the mesenchyme. *, **, ^, ^^ indicates p ≤ 0.05 for the specified groups.
Error bars represent the standard error of the mean. DMSO (n=5), IWP-2 (n=4), XAV939 (n=2).
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Table 2: Analysis of variance of Pax3+/Islet1+ cells in the mesenchyme (groups include DMSO,
IWP, and XAV939 treatment)
Source

DF

SS

MS

F-value

p-value

Model

2

1291.37

645.68

4.79

0.0123

Error

52

7006.34

134.74

Corrected Total

54

8297.71
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We checked the effectiveness of the inhibitor XAV939 by performing whole mount in situ
hybridization. The embryos used were heads that had been collected at 8-10ss and cultured in
XAV939 through the CMC and compared with embryos that were incubated for 2 days (to
mimic the same stage at which the cultured heads were collected). I used Axin2 as an antisense
probe to indicate the activity of Wnt. XAV939 specifically targets Axin2 protein, rather than
mRNA, so while the Axin2 protein levels would normally be increased if it was effective, the
mRNA levels should decrease as Wnt has been seen to be a transcriptional inducer of Axin2
(Chen et al., 2009, Jho et al., 2002).
The in situs showed that there was little to no Axin2 mRNA in the treated embryos
qualitatively compared to the control embryos (Fig 6A-D) suggesting little Wnt canonical
activity. Even in the control embryos, however, it seemed that there was scant Wnt activity in the
placode region, as indicated by Axin2 levels. Sections of the embryo in the opV placode region
showed good expression however of Axin2 in the dorsal ectoderm (Fig 6H) and in the otic
placode region (6E, 6F) in the controls. The embryos treated with XAV939 showed no staining
at all (Fig 6G, 6H). This indicates the inhibitor effectively blocked Wnt signaling in our
experimental approach. Synthesizing these data with what was found by Lassiter et al. yields the
possibility that Pax3 expression and placode identity is regulated independent of Wnt/β-catenin
through TCF at both the induction and maintenance stages.
Overall, these experiments showed that inhibition of Wnt activity throughout the entire
head of the embryo still only resulted in a decrease of differentiated placode cells in the
mesenchyme and no difference in the undifferentiated (Pax3-expressing) cells in the ectoderm, a
different result from what had been previously reported (Lassiter et al., 2007).
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Figure 6: Staining of Axin2 Expression Showing Spatiotemporal Activity of Wnt Signaling on
Experimental and Treated Chicken Embryos
In situ hybridization staining for the scaffold protein Axin2, which is often used as a readout for
canonical Wnt signaling, appears to be scant in the experimental embryos versus the control
embryos. Axin2+ ectoderm can be seen in the dorsal head ectoderm of the controls, especially in
specific regions near the otic vesicles. 48-hr embryos were collected as controls (A,B, E, F, H) to
compare with 8-10ss embryos treated with XAV939 and culture as per the CMC protocol for 24
h (C, D, G I). Axin2 staining in sections of wild type otic region (E) and the anterior edge of the
otic region (F). Axin2 staining in a section of the otic region in the treated embryos (G). Axin2
staining in a section of the dorsal ectoderm in the midbrain in a wildtype embryo (H). Axin2
staining in a section of the dorsal ectoderm in the midbrain in a treated embryo (I).
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Wnt Secretion from NCCs an Important Factor in Developing Structures from NCC Streams 1,
2, and 3
Our other goal conditionally knockout Wnt secretion from the dorsal NT to see if it was
the source of Wnt signals affecting the opV placode. This was a follow-up to work done by Jason
Adams but was more specifically and severely knocking out Wnt secretion in the NT and NCCs.
I crossed a Wnt1-cre male with a Porcn mutant female; Wnt1-cre:Porcn mutants were identified
by the presence of the Sry and Cre genes in their genotypes. Mice were collected at E8.5 and
E10.5 and observed for morphological differences but none were observed and there were
relatively few mutants produced in each litter. These embryos were also processed through
cryosectioning and immunohistochemistry but little to no differences were seen in Pax3 and
Islet1 expression (data not included). At this time, I was using a Wnt1-cre driver line from Dr.
Fuhrmann (University of Utah) and it wasn’t known to be the most effective Wnt1-cre available,
which could have contributed to the lack of defects seen early on. I wanted to check to see if any
abnormal morphologies could be observed at birth or whether it was a lethal mutation, so I let the
embryos go to birth. One mutant was obtained that showed micrognathia and abnormal
presentation of the ears that seemed consistent with phenotypes of craniofacial disorders.
We obtained a new Wnt1-cre male and female from Jackson Labs (Stock # 022137), due
to new facility requirements. After breeding the new Wnt1-cre line with our Porcn knockout
mice, I continued to find mutants who presented the previously observed phenotype. Mice were
collected as newborns. Skeletal preps were then performed on these fetuses to compare bone and
cartilage formation between the mutant and wildtype mice. The abnormalities in the mutant mice
were very similar to those seen in Wnt1-cre conditional knockouts of β-catenin from Brault et al.
(2001). The trunk skeleton, it seemed, had no abnormal structures or malformations compared to
the wild type; this included limbs and vertebral structures up until the atlas bone. In the head
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region, however, most of the bone structures that were derived from cranial NCCs were absent in
the mutant mice. In fact, there was almost no ossification in the head except for the exooccipital
bones (compare Fig 7A and 7B). Cartilage from the mandible was present but other structures
from pharyngeal arch 1—the maxilla, incus, malleus, and tympanic ring—were missing (Fig 7AD, 7E, 7F). The stapes and the lesser horn of the hyoid bone from pharyngeal arch 2 (Fig 7E-7H)
and pharyngeal arch 3 structures, the lower rim and greater horn of the hyoid bone, were missing
as well (Fig 7G-7J). All that was evident of the hyoid bone in the mutant was cartilage from the
body of the hyoid (Fig 7H). These results suggested a strong necessity for Wnt secretion either
from the NCCs or the dorsal NT.
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Figure 7: Alizarin Red/Alcian Blue Staining of the Collagen and Bone Structures in Wnt1-cre:
Porcn Mice
Skeletal preparations of 18.5 dpc wild-type (A, C, E, G, I) and Porcn mutant (B, D, F, H, J)
fetuses stained with Alizarin Red and Alcian Blue. (A,B) Lateral views of the full skeleton. (C-J)
Zoomed-in views of the head and neck region to show defects. In the mutant, most of the skeletal
structures derived from cranial NCCs are missing except the exoccipital (e) bones and
cartilaginous templates for the mandible (d), the maxilla (x), the frontal bone (f), the parietal
bone (p) the body of the hyoid (b-hy), the malleus (ma), and the otic capsule (o). The tympanic
ring (tr), lesser (lh-hy) and greater horns of hyoid bone (gh-hy), stapes (sa), and incus (i) all seem
to be missing from the mutant. b-hy, body of the hyoid bone; d, mandible; e, exoccipital bones; f,
frontal bone; gh-hy, greater horn of the hyoid bone; i, incus; lh-hy, lesser horn of hyoid bone; m,
malleus; mc, Meckel’s cartilage; nc, nasal capsule;o, optic capsule; p, parietal bone; px, incisive
(premaxillary) bone; sa, stapes; tr, tympanic ring; x, maxilla.
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DISCUSSION
Wnt is an important factor in sensory neurogenesis as has been seen in past research
(Lassiter et al., 2007, Canning et al., 2008, Litsiou et al., 2005, Shigetani et al., 2008). It is
thought to be a potential inducing signal from the NT, although this source of Wnt is no longer
required after the initial induction of the opV placode. Wnt has been suggested to be required for
maintenance of Pax3 expression and thus opV placode cells (Lassiter et al., 2007). There have
also been several studies that have linked canonical Wnt signaling to Pax3 expression through
the caudal-related homeobox (Cdx) family and msh homeobox 1 (Msx1) acting on various
enhancers for the Pax3 gene (Miller et al.,. 2007, Bang et al., 1999, Moore et al., 2013, Zhao et
al., 2014, Sanchez-Ferras et al., 2014). In this study, however, global inhibition of Wnt signaling
by known Wnt inhibitors surprisingly did not eliminate Pax3 expression or neuronal
differentiation in the opV placode. While prior studies point to Wnt being an upstream regulator
of Pax3 expression, the results presented here have made the role of Wnt unclear.
In considering how the seemingly contradictory data sets might be reconciled, the
regulation of TCF/Lef was more closely evaluated. It is perhaps possible that the previous
studies, which have focused heavily on the activity of transcription activator TCF/Lef, have not
examined the possibility of Wnt/β-catenin-independent regulation of TCF. There have been a
few studies that have seen activation of TCF/Lef in other developmental processes and systems
through alternate routes other than Wnt signaling (Fuhrmann et al., 2009, Sprowl and Waterman
2013, Grumolato et al., 2013). They have demonstrated a few connections between the TCF
family and the activating transcription factor (ATF) family. Interestingly, ATF5 has been found
to be expressed highly in the ventricular zone of the developing central nervous system and has
known roles in the progression of neural progenitor cells to become neurons (Angelastro et al.,
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2003, Mason et al., 2005). It has also been seen to modulate signals required for the development
of other neural structures such as oligodendrocytes and astrocytes (Mason 2005, Angelastro et
al., 2005). More specifically, there has been evidence provided showing specific binding
interactions of ATF1 and TCF1 in hematopoietic tumor cells as well as a proven interaction
between ATF5 and TCF4 (Grumolato et al., 2013, Xiongjun et al., 2013). Thus, future studies
could investigate the maintenance of Pax3 via TCF regulation without contributions from Wnt
signaling, or Wnt-independent regulation of TCF target genes.
The other interesting experimental result was the presentation of severe abnormalities in
NC structures from the Porcn knockout mice. The novel part of the work was that the Wnt1cre:Porcn mouse would be suppressing secretion of all Wnt ligands rather than activity of just
the canonical Wnt pathway (as was done with the β-catenin conditional knockout). It provides a
novel approach (inhibiting Wnt secretion via a Porcn knockout) that validates the predominant
hypothesis that Wnt from the dorsal NT is required for induction and expansion of NCCs (Brault
et al., 2001; Chang and Hemmati-Brivanlou, 1998; Dorsky et al., 1998; Garcia-Castro et al.,
2002; Ikeya et al., 1997; LaBonne and Bronner-Fraser, 1998; Lewis et al., 2004; Saint-Jeannet et
al., 1997). It also raises the possibility that Wnt secretion from the NCCs themselves (targeted by
using Wnt1-cre as a driver) plays a role in the formation of these structures, especially since
there were a few differences in abnormal structures between our Wnt1-cre:Porcn mutants and
the Wnt1-cre:β-catenin knockouts (Brault et al., 2001).
Follow-up work on the Wnt1-cre:Porcn mice could also provide good evidence on the
neural development in those embryos as well as further elucidating the role of Wnt in
craniofacial development. Work has been done in which Wnt1-cre was used as a driver line to
inactivate β-catenin; it resulted in a more extreme phenotype of craniofacial defects as well as
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abnormal development of the trigeminal ganglion—all connecting parts with the hindbrain were
lost in the mutants and the mutant ganglion appeared to be much smaller than the wildtype
(Brault et al., 2001). The interesting point is that, in spite of the loss of canonical Wnt activity as
early as E9 in the β-catenin knockout mice, the ganglion was still able to develop, which could
be due to the continued activity of other Wnts outside of the dorsal neural tube. An in vivo study
of the Porcn knockout and the trigeminal nerve could provide additional comparative
information regarding the differential effects of Wnt activity versus Wnt secretion. It could also
shed more light on the result in our chicken tissue cultures that there was no significant
difference between the two different Wnt inhibitor treatments; secretion and activity of Wnt
seemed to affect the embryos similarly in the placode.

29

REFERENCES
Adams, J. S. 2012. "Regulation of Sensory Neurogenesis in the Trigeminal Placode: Notch
Pathway Genes, Pax3 Isoforms, and Wnt Ligands." Doctor of Philosophy, Brigham Young
University.
Angelastro, J. M., T. N. Ignatova, V. G. Kukekov, D. A. Steindler, G. B. Stengren, C.
Mendelsohn, and L. A. Greene. 2003. "Regulated Expression of ATF5 is Required for the
Progression of Neural Progenitor Cells to Neurons." The Journal of Neuroscience : The
Official Journal of the Society for Neuroscience 23 (11): 4590-4600.
Artinger, K. B. and M. Bronner-Fraser. 1993. "Delayed Formation of the Floor Plate After
Ablation of the Avian Notochord." Neuron 11 (6): 1147-1161.
Baker, C. V. and M. Bronner-Fraser. 2001. "Vertebrate Cranial Placodes I. Embryonic
Induction." Developmental Biology 232 (1): 1-61.
Bang, A. G., N. Papalopulu, M. D. Goulding, and C. Kintner. 1999. "Expression of Pax-3 in the
Lateral Neural Plate is Dependent on a Wnt-Mediated Signal from Posterior Nonaxial
Mesoderm." Developmental Biology 212 (2): 366-380.
Barrott, J. J., G. M. Cash, A. P. Smith, J. R. Barrow, and L. C. Murtaugh. 2011. "Deletion of
Mouse Porcn Blocks Wnt Ligand Secretion and Reveals an Ectodermal Etiology of Human
Focal Dermal hypoplasia/Goltz Syndrome." Proceedings of the National Academy of
Sciences of the United States of America 108 (31): 12752-12757.
Brault, V., R. Moore, S. Kutsch, M. Ishibashi, D. H. Rowitch, A. P. McMahon, L. Sommer, O.
Boussadia, and R. Kemler. 2001. "Inactivation of the Beta-Catenin Gene by Wnt1-CreMediated Deletion Results in Dramatic Brain Malformation and Failure of Craniofacial
Development."Development (Cambridge, England) 128 (8): 1253-1264.
Breckpot, J., B. M. Anderlid, Y. Alanay, M. Blyth, A. Brahimi, B. Duban-Bedu, O. Goze, et al.
2015. "Chromosome 22q12.1 Microdeletions: Confirmation of the MN1 Gene as a Candidate
Gene for Cleft Palate." European Journal of Human Genetics : EJHG.
Canning, C. A., L. Lee, S. X. Luo, A. Graham, and C. M. Jones. 2008. "Neural Tube Derived
Wnt Signals Cooperate with FGF Signaling in the Formation and Differentiation of the
Trigeminal Placodes." Neural Development 3: 35-8104-3-35.
Chang, C. and A. Hemmati-Brivanlou. 1998. "Neural Crest Induction by Xwnt7B in
Xenopus." Developmental Biology 194 (1): 129-134.
Chapman, S. C., J. Collignon, G. C. Schoenwolf, and A. Lumsden. 2001. "Improved Method for
Chick Whole-Embryo Culture using a Filter Paper Carrier." Developmental Dynamics : An
Official Publication of the American Association of Anatomists 220 (3): 284-289.

30

Chen, B., M. E. Dodge, W. Tang, J. Lu, Z. Ma, C. W. Fan, S. Wei, et al. 2009. "Small MoleculeMediated Disruption of Wnt-Dependent Signaling in Tissue Regeneration and
Cancer." Nature Chemical Biology 5 (2): 100-107.
Cordas, E. A., L. Ng, A. Hernandez, M. Kaneshige, S. Y. Cheng, and D. Forrest. 2012. "Thyroid
Hormone Receptors Control Developmental Maturation of the Middle Ear and the Size of the
Ossicular Bones." Endocrinology 153 (3): 1548-1560.
D'Amico-Martel, A. and D. M. Noden. 1983. "Contributions of Placodal and Neural Crest Cells
to Avian Cranial Peripheral Ganglia." The American Journal of Anatomy 166 (4): 445-468.
Darnell, D. K. and G. C. Schoenwolf. 2000. "Culture of Avian Embryos." Methods in Molecular
Biology (Clifton, N.J.) 135: 31-38.
Dorsky, R. I., R. T. Moon, and D. W. Raible. 1998. "Control of Neural Crest Cell Fate by the
Wnt Signalling Pathway." Nature 396 (6709): 370-373.
Fuhrmann, S., A. N. Riesenberg, A. M. Mathiesen, E. C. Brown, M. L. Vetter, and N. L. Brown.
2009. "Characterization of a Transient TCF/LEF-Responsive Progenitor Population in the
Embryonic Mouse Retina." Investigative Ophthalmology & Visual Science 50 (1): 432-440.
Garcia-Castro, M. I., C. Marcelle, and M. Bronner-Fraser. 2002. "Ectodermal Wnt Function as a
Neural Crest Inducer." Science (New York, N.Y.) 297 (5582): 848-851.
Grumolato, L., G. Liu, T. Haremaki, S. K. Mungamuri, P. Mong, G. Akiri, P. Lopez-Bergami, et
al. 2013. "Beta-Catenin-Independent Activation of TCF1/LEF1 in Human Hematopoietic
Tumor Cells through Interaction with ATF2 Transcription Factors." PLoS Genetics 9 (8):
e1003603.
Hamburger, V. 1961. "Experimental Analysis of the Dual Origin of the Trigeminal Ganglion in
the Chick Embryo." The Journal of Experimental Zoology 148: 91-123.
Henrique, D., J. Adam, A. Myat, A. Chitnis, J. Lewis, and D. Ish-Horowicz. 1995. "Expression
of a Delta Homologue in Prospective Neurons in the Chick." Nature 375 (6534): 787-790.
Huang, S. M., Y. M. Mishina, S. Liu, A. Cheung, F. Stegmeier, G. A. Michaud, O. Charlat, et al.
2009. "Tankyrase Inhibition Stabilizes Axin and Antagonizes Wnt Signalling." Nature 461
(7264): 614-620.
Ikeya, M., S. M. Lee, J. E. Johnson, A. P. McMahon, and S. Takada. 1997. "Wnt Signalling
Required for Expansion of Neural Crest and CNS Progenitors." Nature 389 (6654): 966-970.
Jho, E. H., T. Zhang, C. Domon, C. K. Joo, J. N. Freund, and F. Costantini. 2002. "Wnt/betacatenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the
Signaling Pathway." Molecular and Cellular Biology 22 (4): 1172-1183.

31

Karlberg, T., N. Markova, I. Johansson, M. Hammarstrom, P. Schutz, J. Weigelt, and H. Schuler.
2010. "Structural Basis for the Interaction between Tankyrase-2 and a Potent Wnt-Signaling
Inhibitor." Journal of Medicinal Chemistry 53 (14): 5352-5355.
LaBonne, C. and M. Bronner-Fraser. 1998. "Neural Crest Induction in Xenopus: Evidence for a
Two-Signal Model." Development (Cambridge, England) 125 (13): 2403-2414.
Lassiter, R. N., C. M. Dude, S. B. Reynolds, N. I. Winters, C. V. Baker, and M. R. Stark. 2007.
"Canonical Wnt Signaling is Required for Ophthalmic Trigeminal Placode Cell Fate
Determination and Maintenance." Developmental Biology 308 (2): 392-406.
Lassiter, R. N., S. B. Reynolds, K. D. Marin, T. F. Mayo, and M. R. Stark. 2009. "FGF Signaling
is Essential for Ophthalmic Trigeminal Placode Cell Delamination and
Differentiation." Developmental Dynamics : An Official Publication of the American
Association of Anatomists 238 (5): 1073-1082.
Lewis, J. L., J. Bonner, M. Modrell, J. W. Ragland, R. T. Moon, R. I. Dorsky, and D. W. Raible.
2004. "Reiterated Wnt Signaling during Zebrafish Neural Crest Development." Development
(Cambridge, England) 131 (6): 1299-1308.
Litsiou, A., S. Hanson, and A. Streit. 2005. "A Balance of FGF, BMP and WNT Signalling
Positions the Future Placode Territory in the Head."Development (Cambridge, England) 132
(18): 4051-4062.
Liu, W., Y. Lan, E. Pauws, M. A. Meester-Smoor, P. Stanier, E. C. Zwarthoff, and R. Jiang.
2008. "The Mn1 Transcription Factor Acts Upstream of Tbx22 and Preferentially Regulates
Posterior Palate Growth in Mice." Development (Cambridge, England) 135 (23): 3959-3968.
Liu, Y., M. Wang, W. Zhao, X. Yuan, X. Yang, Y. Li, M. Qiu, X. J. Zhu, and Z. Zhang. 2015.
"Gpr177-Mediated Wnt Signaling is Required for Secondary Palate Development." Journal
of Dental Research.
Mason, J. L., J. M. Angelastro, T. N. Ignatova, V. G. Kukekov, G. Lin, L. A. Greene, and J. E.
Goldman. 2005. "ATF5 Regulates the Proliferation and Differentiation of
Oligodendrocytes." Molecular and Cellular Neurosciences 29 (3): 372-380.
McCabe, K. L., J. W. Sechrist, and M. Bronner-Fraser. 2009. "Birth of Ophthalmic Trigeminal
Neurons Initiates Early in the Placodal Ectoderm." The Journal of Comparative
Neurology 514 (2): 161-173.
Miller, K. A., J. Barrow, J. M. Collinson, S. Davidson, M. Lear, R. E. Hill, and A. Mackenzie.
2007. "A Highly Conserved Wnt-Dependent TCF4 Binding Site within the Proximal
Enhancer of the Anti-Myogenic Msx1 Gene Supports Expression within Pax3-Expressing
Limb Bud Muscle Precursor Cells." Developmental Biology 311 (2): 665-678.

32

Moore, S., V. Ribes, J. Terriente, D. Wilkinson, F. Relaix, and J. Briscoe. 2013. "Distinct
Regulatory Mechanisms Act to Establish and Maintain Pax3 Expression in the Developing
Neural Tube." PLoS Genetics 9 (10): e1003811.
Sahoo, T., A. Theisen, P. A. Sanchez-Lara, M. Marble, D. N. Schweitzer, B. S. Torchia, A. N.
Lamb, B. A. Bejjani, L. G. Shaffer, and Y. Lacassie. 2011. "Microdeletion 20p12.3
Involving BMP2 Contributes to Syndromic Forms of Cleft Palate." American Journal of
Medical Genetics.Part A 155A (7): 1646-1653.
Saint-Jeannet JP. Patterning the Vertebrate Neural Plate by Wnt Signaling. In: Madame Curie
Bioscience Database [Internet]. Austin (TX): Landes Bioscience; 2000-. Available from:
http://www.ncbi.nlm.nih.gov/books/NBK6533/
Saint-Jeannet, J. P., X. He, H. E. Varmus, and I. B. Dawid. 1997. "Regulation of Dorsal Fate in
the Neuraxis by Wnt-1 and Wnt-3a." Proceedings of the National Academy of Sciences of the
United States of America 94 (25): 13713-13718.
Sanchez-Ferras, O., G. Bernas, E. Laberge-Perrault, and N. Pilon. 2014. "Induction and Dorsal
Restriction of Paired-Box 3 (Pax3) Gene Expression in the Caudal Neuroectoderm is
Mediated by Integration of Multiple Pathways on a Short Neural Crest
Enhancer." Biochimica Et Biophysica Acta 1839 (7): 546-558.
Shigetani, Y., S. Howard, S. Guidato, K. Furushima, T. Abe, and N. Itasaki. 2008. "Wise
Promotes Coalescence of Cells of Neural Crest and Placode Origins in the Trigeminal
Region during Head Development." Developmental Biology 319 (2): 346-358.
Sprowl, S. and M. L. Waterman. 2013. "Past Visits Present: TCF/LEFs Partner with ATFs for
Beta-Catenin-Independent Activity." PLoS Genetics 9 (8): e1003745.
Stark, M. R., J. J. Biggs, G. C. Schoenwolf, and M. S. Rao. 2000. "Characterization of Avian
Frizzled Genes in Cranial Placode Development."Mechanisms of Development 93 (1-2): 195200.
Stark, M. R., J. Sechrist, M. Bronner-Fraser, and C. Marcelle. 1997. "Neural Tube-Ectoderm
Interactions are Required for Trigeminal Placode Formation." Development (Cambridge,
England) 124 (21): 4287-4295.
Sun, Y., I. M. Dykes, X. Liang, S. R. Eng, S. M. Evans, and E. E. Turner. 2008. "A Central Role
for Islet1 in Sensory Neuron Development Linking Sensory and Spinal Gene Regulatory
Programs." Nature Neuroscience 11 (11): 1283-1293.
Voelkel, J. E., J. A. Harvey, J. S. Adams, R. N. Lassiter, and M. R. Stark. 2014. "FGF and Notch
Signaling in Sensory Neuron Formation: A Multifactorial Approach to Understanding
Signaling Pathway Hierarchy." Mechanisms of Development 134: 55-66.

33

Wu, D., S. Mandal, A. Choi, A. Anderson, M. Prochazkova, H. Perry, V. L. Gil-da-Silva-Lopes,
et al. 2015. "DLX4 is Associated with Orofacial Clefting and Abnormal Jaw
Development." Human Molecular Genetics.
Ye, X., Z. Zhang, X. Zhang, G. Lin, S. Xiong, G. Jin, L. Han, et al. 2003. "Functional Interaction
of TCF4 with ATF5 to Regulated the Wnt Signaling Pathway." Chinese Science Bulletin 48
(7): 668.
Zhao, T., Q. Gan, A. Stokes, R. N. Lassiter, Y. Wang, J. Chan, J. X. Han, D. E. Pleasure, J. A.
Epstein, and C. J. Zhou. 2014. "Beta-Catenin Regulates Pax3 and Cdx2 for Caudal Neural
Tube Closure and Elongation." Development (Cambridge, England) 141 (1): 148-157.

34

CURRICULUM VITAE
Julie Hulet
1823 Cinema Dr
Fuquay-Varina, NC 27526
814.360.8800 juliel.hulet@gmail.com
EDUCATION
May 2019
Aug 2014
Aug 2009

D.O. Medicine: Campbell University School of Osteopathic Medicine
M.S Physiology and Developmental Biology: Brigham Young University
B.S. Physiology and Developmental Biology: Brigham Young University
Minor: Editing

WORK EXPERIENCE
Sep 2012- Jun 2015

Research Assistant: BYU





Sep 2011-Apr 2015

Mastered lab techniques such as PCR, In Situ Hybridization, and
embryo collection
Worked cooperatively with teams to gather data for both
Mentored undergraduate students in lab work and setting up
experiments
Teaching Assistant: BYU













Provo, UT

Prevented and solved on-air problems regularly and at all hours of the
day
Helped train new operators in managing broadcasting schedules and
fixing discrepancies on-air
Edited the training manual

May 2008-Aug 2008 Lab Technician Assistant: USDA-ARS Pasture Lab
May 2007-Aug 2007


Provo, UT

Helped with the following courses: PDBIO 562 Reproductive
Physiology, PDBIO484 Embryology, PDBIO 482 Developmental
Biology, ELANG 410R Technical Editing/Editing for Scholarly
Publishing
Assisted all the professors in grading, taught when the professor was
absent, and held regular review sessions for the students
Class numbers were anywhere between 23 and 44 students

Sep 2006 – May 2012 Master Control Operator: BYU Broadcasting


Provo, UT

Collected and analyzed data for the primary researchers
General care of research plots
35

Provo, UT

OTHER EXPERIENCE
Aug 2013-Jun 2014 Cancer Resource Center Volunteer Chair: Utah Valley Regional Medical
Center (UVRMC)
Provo, UT





Jun 2013-Jul 2014

Responsible for scheduling and training about 10 volunteers
Organizing events to unite the volunteers and help improve volunteer
work
Meeting with the American Cancer Society Staff regularly to manage
volunteers

Wound Care Volunteer: UVRMC





Ushered patients into the exam rooms to take vital signs and prepare
patient for the nurse
Clean, disinfect, and set up rooms after each patient
Aided the secretaries with their work when needed

Jan 2012-Dec 2013 Cancer Resource Center Volunteer: UVRMC








Provo, UT

Data Entry for program and information requests
Answering questions for the patients and their families and helping
them find information
Helping the patients feel welcome and happy.

Sep 2008 – Jun 2012 Assistant Lab Researcher: BYU


Provo, UT

Provo, UT

Team leader for PCR and genotyping mice
Aided in embedding, sectioning, and staining mouse embryos
Trained team and other individuals in PCR and gel electrophoresis
procedures

AWARDS
Aug 2012-May 2015

Research Assistantships (7): Department of Physiology and
Developmental Biology (BYU)
Provo, UT

Aug 2012-Jan 2015

Teaching Assistantship (5): Department of Physiology and
Developmental Biology (BYU)
Provo, UT

PUBLICATIONS
2015-2016

In progress: Comparative morphological and molecular evidence supports
an essential role for embryonic timing in determining anterior-posterior
limb position. Stark, M. Prestwich, T. Hulet, J. Stephens, T.
36

